U.S. Hospital Infection Control Equipment Market

Market Outlook

By 2035, the U.S. Hospital Infection Control Equipment Market is expected to reach approximately USD 8.33 billion, expanding at a CAGR of 8.40% during the forecast period 2026–2035. The market is estimated at USD 3.72 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The market expanded from approximately USD 2.80 billion in 2021 to USD 3.46 billion in 2024, reflecting sustained investment in sterile processing departments, automated device reprocessing, operating-room decontamination, endoscope reprocessing, air-management infrastructure, and hospital-wide environmental hygiene systems. The market is projected to rise to approximately USD 4.03 billion in 2026, USD 5.57 billion by 2030, and USD 8.33 billion by 2035 as infection prevention becomes more deeply embedded in hospital capital planning and quality-performance strategies.

The scope of this market is intentionally centered on hospital-purchased capital and durable infection-control equipment. It covers steam and low-temperature sterilizers, washer-disinfectors, ultrasonic cleaning equipment, automated endoscope reprocessors, liquid chemical processing systems, drying and storage systems, ultraviolet and other no-touch room decontamination equipment, selected air-decontamination and filtration systems, sterile-processing monitoring hardware, and related workflow-control equipment. Bulk disinfectant chemistry, personal protective equipment, contract sterilization services, disposable protective barriers, and industrial sterilization performed outside hospitals are excluded from the core sizing.

U.S. hospitals remain under persistent pressure to reduce healthcare-associated infections while maintaining procedure throughput. Recent national surveillance indicates that approximately one in 38 hospitalized patients had at least one healthcare-associated infection on a given day in 2023. Although this represents a meaningful improvement compared with earlier national prevalence levels, infection risk remains economically and clinically material across surgical departments, intensive care units, endoscopy suites, emergency departments, oncology services, transplant programs, and other high-acuity settings.

The U.S. hospital infrastructure itself creates a substantial recurring equipment base. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and about 35.7 million annual hospital admissions. Every high-volume hospital operates multiple infection-control workflows extending from instrument receipt and decontamination through cleaning, inspection, sterilization, storage, transportation, room turnover, terminal cleaning, and documentation. The result is a market driven not simply by new facility construction but by replacement cycles, capacity additions, equipment redundancy, regulatory compliance, instrument complexity, and workflow modernization.

Hospital purchasing decisions are also changing. Infection-control equipment is increasingly assessed through total workflow economics rather than acquisition price alone. Chief financial officers, sterile processing leaders, infection preventionists, perioperative executives, biomedical engineering teams, and value-analysis committees evaluate whether new systems can shorten cycle times, reduce instrument damage, lower labor requirements, improve traceability, prevent procedural delays, reduce aborted cycles, improve room utilization, and strengthen documentation for accreditation and quality review.

This shift favors equipment platforms with higher throughput, automated documentation, better device compatibility, lower utility consumption, standardized cycle validation, and connectivity with hospital information systems. The result is a market in which capital intensity is rising even as hospitals remain highly cost-conscious.

Introduction

According to the U.S. Hospital Infection Control Equipment Market Report, infection-control infrastructure is moving from a support function toward a strategically protected component of hospital operations. Sterile processing failures, inadequate device reprocessing, contaminated reusable instruments, delayed turnaround, incomplete drying, environmental contamination, and inconsistent infection-prevention workflows can directly affect patient safety, operating-room schedules, accreditation performance, clinical outcomes, and hospital economics.

The market therefore extends well beyond conventional autoclaves. Modern hospitals require a coordinated equipment ecosystem that includes central sterile processing equipment, automated washers, ultrasonic cleaners, low-temperature sterilizers for heat-sensitive instruments, automated endoscope reprocessors, scope drying cabinets, probe disinfection systems, room decontamination technologies, air-management solutions, biological indicator readers, tracking hardware, and digitally connected workflow tools.

The demand environment is reinforced by measurable healthcare-associated infection performance requirements. National acute-care hospital data have demonstrated meaningful reductions in several HAIs, including central line-associated bloodstream infections, catheter-associated urinary tract infections, hospital-onset MRSA bacteremia, and C. difficile infection. However, progress is uneven by infection type and healthcare setting, and surgical-site infection performance remains a persistent operational challenge for many facilities.

For hospital executives, infection prevention has a direct financial dimension. Medicare’s Hospital-Acquired Condition Reduction Program incorporates healthcare-associated infection measures into hospital quality scoring. Hospitals in the worst-performing quartile can receive a 1% reduction in overall Medicare fee-for-service payments for the applicable fiscal year. This connects infection-control performance with reimbursement economics and gives capital committees a stronger business case for investments that improve reprocessing consistency, environmental controls, documentation, and compliance.

The equipment market is also benefiting from increasing device complexity. Robotic surgical instruments, advanced minimally invasive devices, flexible endoscopes, ultrasound probes, camera systems, powered instruments, 3D-printed components, electronics, batteries, and thermolabile medical devices cannot always be processed using conventional steam sterilization. Hospitals therefore need multiple validated reprocessing modalities rather than a single sterilization technology.

A modern sterile processing department can consequently operate steam sterilizers alongside vaporized hydrogen peroxide systems, washer-disinfectors, ultrasonic cleaning systems, cart washers, instrument tracking systems, biological indicator readers, and specialized drying equipment. Endoscopy departments add automated endoscope reprocessors, drying cabinets, leak-testing systems, transport solutions, and traceability technologies.

From 2026 through 2035, equipment suppliers capable of solving an entire workflow problem will gain strategic advantage over vendors selling isolated hardware. Hospitals increasingly want integrated systems supported by service coverage, validated compatibility, staff education, uptime guarantees, preventive maintenance, cycle documentation, utilization analytics, and enterprise-level procurement agreements.

Key Market Drivers: What’s Fueling the U.S. Hospital Infection Control Equipment Market Boom?

The first major growth driver is the persistent clinical and economic burden of healthcare-associated infections. Improvements in infection rates do not eliminate the need for prevention infrastructure; they reinforce the value of reliable infection-control systems. Hospitals must maintain high compliance across millions of patient encounters while managing invasive devices, surgery, endoscopy, intensive care, isolation, emergency care, and immunocompromised populations. A single lapse in reprocessing or environmental controls can have consequences disproportionate to the cost of the equipment intended to prevent it.

The second driver is the scale and utilization intensity of the U.S. hospital system. More than 907,000 staffed beds and approximately 35.7 million annual admissions create high recurring volumes for instrument processing, patient-room turnover, operating-room cleaning, device disinfection, and sterile storage. Large health systems may operate multiple central sterile processing departments and satellite reprocessing locations, generating demand not only for primary equipment but also for redundant capacity, backup equipment, expansion systems, and replacement units.

The third driver is rising procedural and instrument complexity. Hospitals are increasingly performing minimally invasive, robotic, image-guided, orthopedic, cardiovascular, neurosurgical, endoscopic, and other procedures that depend on expensive reusable instrumentation. These devices often have narrow lumens, articulated joints, cameras, electronic components, polymers, adhesives, or heat-sensitive materials. Infection-control equipment must therefore achieve validated microbial effectiveness without shortening instrument life.

This dynamic increases demand for low-temperature sterilization, advanced automated cleaning, specialized ultrasonic systems, endoscope reprocessing technologies, controlled drying, and digital traceability. Equipment suppliers that demonstrate broad device compatibility can create measurable financial value because premature instrument damage can be expensive for hospitals.

The fourth major driver is hospital labor economics. Sterile processing departments remain labor-intensive and require technically trained staff capable of following detailed manufacturer instructions for use. Workforce shortages, training variability, turnover, and increasing procedural complexity are pushing hospitals toward automation. Automated loading guidance, cycle selection, chemical dosing, leak detection, instrument tracking, digital records, workflow alerts, and standardized processing reduce dependence on memory and manual documentation.

Automation does not eliminate the need for skilled technicians, but it changes how hospitals allocate staff. Equipment that allows fewer technicians to safely manage larger processing volumes can deliver a compelling labor-productivity argument.

The fifth driver is the economics of operating-room throughput. Infection-control equipment can become an invisible capacity constraint when reprocessing does not keep pace with surgery. If instrument sets are unavailable, sterilization cycles are delayed, or equipment is offline, surgical schedules may be disrupted. Hospitals increasingly evaluate sterile-processing investments as part of perioperative capacity planning.

High-throughput sterilizers, faster low-temperature cycles, larger washer capacity, pass-through configurations, optimized loading, predictive maintenance, and improved instrument tracking can reduce turnaround bottlenecks. For high-volume surgical hospitals, preventing even a small number of procedure delays can materially improve the return on capital equipment.

The sixth driver is the increasing scrutiny of reusable-device reprocessing. Flexible endoscopes and other complex devices remain particularly challenging because contamination can persist in difficult-to-clean channels if cleaning, disinfection, drying, storage, or handling is inadequate. This has supported adoption of automated endoscope reprocessors, dedicated drying cabinets, improved transport systems, leak-testing technology, process documentation, and specialized sterilization approaches.

The seventh driver is reimbursement and hospital quality measurement. Infection measures are embedded in federal quality programs, and HAI performance contributes to the economic consequences faced by hospitals. For executive teams, infection-control equipment is therefore linked to patient safety, reputation, accreditation, Medicare economics, litigation risk, and operational resilience.

The eighth driver is hospital modernization. Many U.S. hospitals are renovating central sterile departments, operating rooms, endoscopy units, procedural areas, intensive care facilities, and air-handling infrastructure. Renovation projects create opportunities to redesign dirty-to-clean workflow, automate loading and transport, install pass-through equipment, increase capacity, improve ventilation, and integrate digital tracking.

A ninth driver is increasing emphasis on sustainability. Steam sterilizers and washer-disinfectors can consume substantial water, energy, and utilities. Hospital sustainability initiatives therefore influence equipment specifications. Buyers increasingly evaluate water consumption per cycle, electrical demand, heat recovery, detergent usage, standby consumption, emissions, equipment footprint, and instrument-life implications.

Finally, infectious-disease preparedness remains structurally important following the COVID-19 era. Hospitals have retained greater awareness of airborne infection control, isolation capacity, rapid room decontamination, respiratory protection workflows, and surge-readiness. This supports selected investment in UV-C, air filtration, negative-pressure support, portable air cleaning, and other technologies that can be deployed during outbreaks.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. hospital infection-control equipment market is increasingly centered on automation, compatibility, speed, environmental performance, and verifiable process control.

Low-temperature sterilization is one of the most strategically important innovation areas. Vaporized hydrogen peroxide and related technologies are becoming more important as medical devices incorporate advanced polymers, electronics, optics, and other materials that may not tolerate high-temperature steam. U.S. regulatory recognition of vaporized hydrogen peroxide as an established sterilization method has strengthened the broader innovation environment around hydrogen-peroxide-based processing.

The competitive objective is no longer simply to complete a sterilization cycle. Hospitals increasingly evaluate how much usable chamber capacity is available, how many instruments can be processed per hour, which device models have validated compatibility, whether complex lumens can be processed, how frequently cycles abort, and how quickly equipment can return instruments to the operating room.

Steam sterilization remains essential and continues to evolve. Modern systems are being designed around higher productivity, improved control systems, utility efficiency, ergonomic loading, automated doors, remote diagnostics, standardized documentation, and integration into high-volume sterile processing departments. For most hospitals, steam will remain the backbone of reusable surgical instrument sterilization even as low-temperature technologies gain share.

Endoscope reprocessing is undergoing another important innovation cycle. Automated endoscope reprocessors are being integrated with electronic records, scope identifiers, user authentication, cycle tracking, leak-testing data, and drying/storage systems. The objective is to create an auditable chain from bedside pre-cleaning through manual cleaning, automated high-level disinfection or sterilization, drying, storage, and reuse.

Controlled drying is becoming especially important because residual moisture can create conditions conducive to microbial persistence. Hospitals are increasingly treating drying cabinets and storage systems as part of the validated reprocessing workflow rather than optional accessories.

Environmental decontamination is also becoming more automated. UV-C systems, pulsed-light systems, hydrogen-peroxide-based room decontamination, and other no-touch technologies are being deployed as adjuncts to manual environmental cleaning. These systems are particularly relevant for isolation rooms, intensive care areas, operating rooms, transplant environments, oncology units, and rooms previously occupied by patients with epidemiologically important organisms.

Airborne infection-control technology represents another emerging equipment layer. Hospitals are evaluating portable HEPA filtration, UV germicidal irradiation, air-cleaning devices, room-level air treatment, and supplemental air-management systems in spaces where ventilation upgrades are difficult or where additional control is clinically justified.

Digital traceability is increasingly connecting all of these technologies. Hospitals want to know which technician handled an instrument, which equipment cycle was used, whether cleaning steps were completed, which patient subsequently received the instrument, and whether maintenance or quality-control requirements were satisfied. Sterile processing therefore is gradually becoming a data-generating operational system rather than a series of isolated machines.

Artificial intelligence will initially have its greatest value in workflow optimization rather than microbial eradication itself. Predictive maintenance, load optimization, equipment utilization analysis, bottleneck identification, staffing forecasts, and automated exception management can improve the economics of large sterile processing departments.

Manufacturers are also raising the competitive bar through lifecycle service. Equipment uptime can be more important than minor differences in acquisition price. Large hospital systems increasingly favor vendors that can provide national service coverage, rapid parts availability, remote diagnostics, preventive maintenance, technical education, workflow consulting, and standardized equipment across multiple hospitals.

Segmentation Insights

The U.S. Hospital Infection Control Equipment Market is segmented on the basis of product category, technology, application, hospital type, and region.

By Product Category

Sterilization Equipment

Sterilization equipment represents the largest product category and includes steam sterilizers, low-temperature sterilizers, selected chemical sterilization systems, dry-heat systems, and supporting sterilization hardware. Steam sterilization retains the largest installed base because it is economical, well established, and appropriate for a broad range of heat- and moisture-compatible surgical instruments.

Low-temperature equipment is expected to generate faster value growth because of the expanding inventory of heat-sensitive medical devices. Hydrogen-peroxide-based systems are particularly attractive to hospitals performing high volumes of minimally invasive, robotic, endoscopic, and advanced surgical procedures.

Replacement demand is substantial because hospitals must maintain equipment reliability, cycle documentation, chamber integrity, and sufficient capacity to avoid disrupting surgical schedules.

Cleaning and Disinfection Equipment

Cleaning and disinfection equipment includes washer-disinfectors, cart washers, ultrasonic cleaning systems, automated cleaning units, flushing systems, and related mechanical decontamination equipment. Cleaning is a critical prerequisite to effective sterilization because residual biological material can compromise downstream processing.

Growth is being supported by hospital efforts to reduce manual variability, improve ergonomic safety, standardize chemical dosing, and increase sterile processing capacity. Large facilities increasingly favor automated equipment capable of handling high instrument volumes while recording cycle performance.

Endoscope and Semi-Critical Device Reprocessing Equipment

This category includes automated endoscope reprocessors, liquid chemical processing systems, endoscope drying and storage cabinets, transport equipment, leak-testing systems, ultrasound-probe disinfection systems, and other device-specific reprocessing platforms.

Demand is particularly strong in gastrointestinal endoscopy, bronchoscopy, urology, ENT, cardiology, and ultrasound-intensive departments. Flexible scopes are expensive, technologically complex, and difficult to reprocess, creating a strong business case for automation and documentation.

The segment will remain strategically important even as selected specialties adopt single-use scopes because reusable GI endoscopy continues to generate very high procedure volumes.

Environmental and Room Decontamination Equipment

Environmental systems include mobile UV-C devices, pulsed-light systems, hydrogen peroxide room decontamination systems, fixed disinfection equipment, and selected automated technologies used as adjuncts to manual cleaning.

Hospitals generally deploy these systems selectively rather than in every patient room. Higher-value use cases include isolation rooms, transplant units, intensive care, oncology, operating rooms, burn units, and outbreak response.

Future adoption will depend increasingly on demonstrated workflow efficiency, room-cycle time, automation, safety controls, coverage validation, and measurable clinical or operational benefit.

Air and Infection-Control Monitoring Equipment

This segment includes hospital air-treatment systems used specifically for infection-risk reduction, portable HEPA systems, UVGI equipment, supplemental air-cleaning technologies, selected negative-pressure support equipment, sterilization monitoring readers, and workflow-control hardware.

Demand accelerated during the pandemic and has since become more targeted. Hospitals now tend to evaluate these systems through engineering controls, room-specific risk, ventilation requirements, infection-prevention protocols, and total lifecycle cost rather than emergency procurement.

By Technology

Steam and Thermal Processing

Steam is the foundational hospital sterilization technology because it is highly effective, standardized, relatively economical per cycle, and compatible with a broad range of reusable instruments. Large hospitals operate multiple sterilizers to provide capacity redundancy.

Future innovation will focus on throughput, water and energy efficiency, automation, remote service, cycle documentation, ergonomics, and chamber utilization rather than replacing the fundamental steam process.

Vaporized Hydrogen Peroxide and Low-Temperature Processing

Low-temperature hydrogen-peroxide-based sterilization is one of the fastest-growing technologies because it addresses devices that cannot tolerate conventional high-temperature processing. Growth is closely connected with increasing minimally invasive and electronically enabled surgical instrumentation.

Hospitals compare systems according to device compatibility, lumen claims, cycle duration, usable chamber volume, consumable costs, instrument durability, utility requirements, and workflow reliability.

Automated Liquid Chemical Disinfection and Sterilization

Liquid chemical systems remain important for flexible endoscopes and other heat-sensitive reusable devices. Automation improves process consistency by controlling exposure conditions, chemistry concentration, rinsing, channel flow, and cycle documentation.

Integration between reprocessors, electronic tracking platforms, leak testing, drying, and storage will increasingly differentiate vendors.

Ultraviolet and No-Touch Environmental Decontamination

UV-C and related no-touch technologies provide an additional layer of environmental decontamination after conventional cleaning. Hospitals value systems that can be deployed efficiently without creating excessive room downtime.

The technology’s market growth will depend on evidence quality, ease of deployment, automation, dose verification, ability to operate around complex room geometry, and integration into environmental services workflows.

Filtration, Air Treatment and Engineering Controls

HEPA filtration, germicidal irradiation, supplemental air treatment, isolation-related equipment, and selected portable systems form a growing engineering-control segment. Adoption is strongest where hospitals need additional protection beyond existing HVAC performance or temporary flexibility during construction, outbreaks, or surge events.

By Application

Surgical Instrument Reprocessing and Central Sterile Processing

Central sterile processing represents the largest application because almost every operating hospital requires reliable instrument cleaning, disinfection, sterilization, inspection, packaging, storage, and distribution.

Capacity planning increasingly reflects surgical volume, instrument-set complexity, robotic programs, orthopedic surgery, trauma demand, and operating-room expansion. High-volume hospitals prioritize equipment uptime and throughput because sterile processing performance directly affects procedural capacity.

Endoscopy and Flexible Device Reprocessing

Endoscopy remains one of the most demanding reprocessing environments. Flexible devices contain channels and complex surfaces that require strict cleaning and disinfection protocols.

U.S. hospitals are investing in automated reprocessors, drying cabinets, workflow segregation, dedicated sinks and flushing equipment, electronic traceability, and staff training. Facilities expanding colorectal screening and GI service lines are particularly important buyers.

Operating Rooms and Procedural Areas

Infection-control equipment used around operating rooms includes sterilization infrastructure, room-decontamination systems, air-management equipment, and mobile environmental technologies.

Surgical-site infection prevention makes this application strategically important because procedure-related infections can lead to substantial additional utilization and quality consequences. Hospitals with orthopedic, cardiac, transplant, neurosurgical, and complex oncology programs tend to have especially rigorous infection-control requirements.

Intensive Care, Isolation and High-Risk Inpatient Areas

Critical care environments combine invasive lines, ventilators, vulnerable patients, high antibiotic exposure, and intensive staff contact. These characteristics create elevated infection-control requirements.

Portable air-cleaning systems, environmental decontamination equipment, isolation-support technologies, and enhanced cleaning tools are particularly relevant in these settings. Equipment purchases may also be incorporated into broader preparedness plans.

Hospital-Wide Environmental and Support Services

Environmental services departments are responsible for thousands of patient-room turnovers, public areas, procedural support spaces, and high-touch surfaces. Automated room decontamination and environmental monitoring systems can supplement conventional manual cleaning in selected high-risk applications.

Hospitals increasingly look for systems that fit existing room-turnover workflows rather than requiring unrealistic downtime or staffing.

By Hospital Type

Large Acute-Care Hospitals and Integrated Health Systems

Large acute-care hospitals represent the dominant customer group because of their surgical volume, multiple procedural departments, intensive care capacity, large reusable-instrument inventory, and higher capital budgets.

Integrated delivery networks increasingly negotiate enterprise contracts covering multiple hospitals and may standardize sterilizers, washers, reprocessors, service agreements, consumables, and software across the system. Winning an IDN standardization decision can therefore generate multi-year revenue for suppliers.

Academic and Teaching Hospitals

Academic medical centers are among the most technically demanding buyers. They perform complex surgery, transplantation, advanced endoscopy, clinical research, and highly specialized procedures involving sophisticated reusable instrumentation.

These institutions frequently serve as early adopters of new sterilization, reprocessing, air-control, and workflow technologies. Their purchasing committees, however, typically require strong clinical validation and economic justification.

Community Hospitals

Community hospitals represent a broad installed base and prioritize reliability, service support, ease of operation, and lifecycle economics. Many facilities face tighter capital budgets than large academic centers and therefore emphasize equipment utilization and standardized configurations.

Replacement cycles in community hospitals provide stable market demand, particularly for steam sterilizers, washer-disinfectors, ultrasonic cleaners, and standard endoscope reprocessing systems.

Critical Access and Rural Hospitals

Critical access and rural hospitals are smaller in absolute revenue but strategically important because they require safe reprocessing despite limited staffing and capital resources. Equipment must often be compact, simple to operate, serviceable over long distances, and flexible across multiple departments.

Remote diagnostics and preventive maintenance can carry disproportionate value because prolonged equipment downtime may force procedures to be transferred to larger hospitals.

Specialty Hospitals

Orthopedic, surgical, cardiovascular, children’s, rehabilitation, cancer, and other specialty hospitals have infection-control requirements determined by their procedure mix. Orthopedic and surgical specialty hospitals may process high volumes of instrument sets, while oncology and transplant-focused facilities emphasize infection protection for immunocompromised patients.

Specialty settings can therefore generate above-average equipment intensity despite having fewer beds than general hospitals.

Regional Insights: Where the Market is Growing Fastest

The U.S. Hospital Infection Control Equipment Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand varies according to hospital capacity, population growth, procedural volumes, age distribution, health-system consolidation, capital investment, academic medical center concentration, rural access, and technology adoption.

The South is estimated to be the largest regional market at approximately USD 1.27 billion in 2025, followed by the West at USD 0.89 billion, Northeast at USD 0.82 billion, and Midwest at USD 0.74 billion. By 2035, these regional markets are projected to reach approximately USD 2.90 billion, USD 2.15 billion, USD 1.75 billion, and USD 1.53 billion, respectively.

South

The South represents the largest U.S. market because it combines rapid population growth, large hospital networks, major tertiary care centers, high procedure volumes, substantial chronic disease burden, and continuing expansion of healthcare infrastructure.

The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, West Virginia, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma, together with the District of Columbia within the broader regional healthcare corridor.

Texas is one of the most important state markets nationally. Houston, Dallas-Fort Worth, Austin, and San Antonio support large academic centers, integrated health systems, children’s hospitals, cancer programs, cardiovascular services, transplant programs, and high-volume surgery. These environments create significant demand for central sterile modernization, large-capacity sterilizers, automated washers, endoscope processing, operating-room infection control, and air-management equipment.

Florida is another major demand center. Its large and aging population drives inpatient admissions, gastrointestinal procedures, orthopedic surgery, cardiovascular care, and other services requiring reusable medical devices. Health systems expanding in South Florida, Tampa, Orlando, Jacksonville, and other metropolitan areas continue to invest in procedural infrastructure and sterile processing capacity.

North Carolina, Georgia, Tennessee, and Virginia are attractive growth states because of expanding metropolitan populations and strong tertiary-care ecosystems. Academic centers and large regional health systems support early adoption of sophisticated sterilization and reprocessing technologies.

Maryland and the District of Columbia have dense concentrations of advanced medical institutions, federal healthcare organizations, research hospitals, and specialty programs. This supports higher-value purchases where evidence, validation, traceability, and system integration are important.

Alabama, Mississippi, Arkansas, Louisiana, Kentucky, West Virginia, and Oklahoma present a different market profile. Large referral hospitals require advanced infection-control infrastructure, while rural hospitals prioritize equipment reliability, compact footprint, remote service, and economical lifecycle costs.

Through 2035, Southern growth will be reinforced by new hospital construction, ambulatory and procedural expansion within health systems, sterile-processing modernization, population migration, and replacement of aging equipment.

West

The West is expected to be the fastest-growing regional market, supported by technology adoption, hospital modernization, strong medtech ecosystems, rapid population growth in selected states, and greater acceptance of digitally connected infection-control platforms.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California represents the region’s largest state opportunity and one of the largest infection-control equipment markets in the country. Its combination of major academic hospitals, integrated delivery networks, large urban populations, biotechnology and medtech activity, high procedural complexity, and aggressive sustainability requirements creates a favorable environment for premium equipment.

California hospitals are particularly relevant for next-generation low-temperature sterilization, environmental decontamination, energy-efficient sterile processing, digital instrument tracking, advanced endoscope reprocessing, and hospital air-quality technology.

Washington and Oregon have highly consolidated health systems and strong adoption of enterprise-level technology. Procurement decisions increasingly emphasize interoperability, standardized workflows, environmental efficiency, staff productivity, and equipment lifecycle management.

Arizona and Nevada are high-growth healthcare markets because of population expansion and aging demographics. New facilities and hospital expansions create greenfield opportunities in which sterile processing departments can be designed around automated workflows rather than retrofitted into older infrastructure.

Colorado and Utah combine population growth with strong specialty-care programs, integrated provider systems, and technologically progressive hospital operations. These states are attractive for suppliers of automated sterile processing, low-temperature systems, and connected reprocessing equipment.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but have specialized logistical needs. Geographic distance and workforce availability make equipment reliability, remote technical support, preventive maintenance, and inventory planning particularly important.

The West is likely to gain national market share through 2035 because hospitals in the region frequently connect infection prevention with digital workflow, sustainability, engineering controls, and broader facility modernization.

Northeast

The Northeast remains one of the highest-value infection-control markets per hospital because of its concentration of academic medicine, complex surgery, older hospital infrastructure, specialty programs, and rigorous procurement standards.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine.

New York is the largest regional state market. Large hospital networks across New York City and surrounding metropolitan areas operate high-volume surgery, endoscopy, transplant, oncology, trauma, and intensive care services. Space constraints create strong demand for equipment that combines high throughput with efficient footprint.

Massachusetts is disproportionately important relative to its population because of its concentration of academic hospitals, biomedical research institutions, specialty medicine, and medical technology development. Facilities in the state frequently act as evaluation centers for new sterilization, reprocessing, environmental, and monitoring technologies.

Pennsylvania and New Jersey provide substantial installed equipment bases across academic centers, regional health systems, children’s hospitals, and community facilities. Replacement cycles for steam sterilizers and washers remain important, while advanced hospitals continue to add low-temperature and digital reprocessing capacity.

Connecticut and Rhode Island benefit from dense healthcare infrastructure and proximity to major Northeast referral networks. Maine, Vermont, and New Hampshire are smaller markets where rural geography increases the value of reliable equipment, service coverage, and remote diagnostics.

The Northeast’s growth rate is likely to remain slightly below the West because of slower population expansion, but revenue per installation can be attractive because institutions frequently purchase higher-specification equipment and comprehensive service agreements.

Hospital renovation is an especially important regional driver. Many Northeast hospitals operate in space-constrained facilities where sterile processing departments must be modernized without major expansion. Vendors capable of improving throughput within existing footprints can gain a meaningful competitive advantage.

Midwest

The Midwest provides a stable, diversified market supported by established healthcare systems, large community hospital networks, academic medicine, high surgical volumes, and a significant installed base requiring replacement.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest regional opportunity, led by Chicago’s concentration of academic centers, tertiary hospitals, children’s hospitals, community systems, and specialty care. High-volume facilities require sophisticated sterile processing and endoscope reprocessing infrastructure.

Ohio has one of the strongest hospital and specialty-care ecosystems in the Midwest. Large health systems operating across Cleveland, Columbus, Cincinnati, and other markets create opportunities for enterprise standardization of sterilizers, washers, reprocessors, and service contracts.

Michigan supports substantial demand through large metropolitan hospital systems and advanced surgical programs. Minnesota is strategically influential because of its medical technology heritage, major integrated providers, and strong focus on clinical workflow innovation.

Indiana, Wisconsin, Missouri, Iowa, and Kansas provide durable demand for sterilization replacement, automated cleaning, endoscope reprocessing, and hospital environmental equipment. Purchasing decisions frequently place strong emphasis on reliability and lifecycle economics.

Nebraska, North Dakota, and South Dakota are smaller markets but important for critical access and regional referral systems. Vendors that provide remote diagnostics, regional service infrastructure, technician education, and flexible equipment configurations can compete effectively.

The Midwest is expected to maintain steady growth through 2035. Its opportunity is less dependent on rapid population expansion and more closely tied to replacement cycles, IDN standardization, labor productivity, instrument complexity, and modernization of existing sterile processing departments.

Key Market Players

The U.S. Hospital Infection Control Equipment competitive landscape is moderately consolidated in core sterilization and reprocessing technologies but substantially more fragmented in environmental decontamination, UV-C, air-treatment, and specialty device processing.

Large competitors increasingly compete through integrated portfolios combining sterilization equipment, washer-disinfectors, reprocessing systems, consumables, maintenance, software, education, and workflow consulting. Smaller specialist companies compete by addressing specific clinical problems such as ultrasound-probe disinfection, room decontamination, UV-C exposure, portable air treatment, or specialized sterile processing.

Some of the key players in the U.S. Hospital Infection Control Equipment industry are:

STERIS plc
Getinge AB
Advanced Sterilization Products
Ecolab Inc.
Olympus Corporation
SteelcoBelimed
Matachana Group
Tuttnauer
Stryker Corporation
Nanosonics Limited
CS Medical LLC
CIVCO Medical Solutions
Consolidated Sterilizer Systems
PRIMUS Sterilizer Company
Skytron LLC
Xenex Disinfection Services
PDI, Inc.
UVDI
Surfacide
TOMI Environmental Solutions
American Ultraviolet
3M Company

STERIS, Getinge, ASP, SteelcoBelimed, Matachana, and Tuttnauer compete heavily in sterilization and sterile-processing infrastructure. Olympus and STERIS are strategically important in endoscope reprocessing, while Nanosonics, CS Medical, and CIVCO address specialized semi-critical device workflows. Xenex, PDI, UVDI, Surfacide, TOMI, and American Ultraviolet participate in environmental and no-touch decontamination technologies.

Competitive differentiation will increasingly depend on throughput, validated device compatibility, cycle reliability, interoperability, service response, sustainability, installed-base economics, staff training, and documentation.

IDN contracting will become increasingly influential. A vendor that standardizes equipment across a multi-hospital network can create downstream revenue from maintenance, replacement systems, accessories, validation, consumables, upgrades, and software integration. Consequently, manufacturers are increasingly positioning themselves as long-term workflow partners rather than transactional capital-equipment suppliers.

Recent Developments

The U.S. Hospital Infection Control Equipment Market has entered an important technology-transition period centered on low-temperature sterilization, sterile-processing productivity, environmental regulation, and infection-performance accountability.

In January 2024, U.S. regulators recognized vaporized hydrogen peroxide as an established Category A sterilization method for medical devices. This development strengthened the regulatory position of hydrogen-peroxide-based sterilization and supports broader innovation around low-temperature processing. For hospitals, the strategic implication is greater availability of medical devices validated for alternative sterilization modalities over time.

In July 2024, Advanced Sterilization Products received U.S. clearance for an updated STERRAD 100NX system configuration incorporating the ULTRA GI cycle and associated instrument tray. The development reflects increasing industry focus on complex gastrointestinal devices and the broader movement toward validated low-temperature processing for challenging reusable instruments.

Environmental regulation is also reshaping the sterilization ecosystem. New U.S. requirements for ethylene oxide commercial sterilization facilities are designed to reduce emissions substantially. Although commercial EtO sterilization differs from routine hospital sterile processing, the regulatory direction increases strategic attention on alternative sterilization technologies, particularly vaporized hydrogen peroxide and other lower-emission modalities.

During 2025, equipment manufacturers continued to focus on sterile processing productivity. Getinge introduced an updated version of its Solsus 66 steam sterilizer with changes intended to improve usability, operational efficiency, and environmental performance. This type of product development reflects the procurement priorities of U.S. hospitals, which increasingly assess sterilizers according to productivity, workflow and lifecycle cost.

In 2025 and 2026, the hospital reimbursement environment continued to reinforce HAI prevention. Medicare’s Hospital-Acquired Condition Reduction Program maintained financial penalties for hospitals in the worst-performing quartile, with infection measures including CLABSI, CAUTI, surgical-site infection, MRSA bacteremia, and C. difficile infection contributing to the evaluation framework.

In April 2026, Advanced Sterilization Products received another U.S. 510(k) decision for its STERRAD 100NX Sterilization System with ALLClear Technology, illustrating the continuing regulatory and product-development activity in low-temperature sterilization.

In July 2026, updated national infection data indicated that about one in 38 hospitalized U.S. patients had at least one healthcare-associated infection on a given day in the 2023 survey, improving from approximately one in 31 in the earlier national comparison. This progress demonstrates that infection-prevention programs can deliver measurable clinical improvement while also showing why hospitals are unlikely to reduce investment: sustaining lower infection rates requires durable infrastructure, standardized processes, trained personnel, surveillance, and reliable reprocessing equipment.

Over the remainder of the forecast period, equipment development is expected to concentrate on faster cycles, validated complex-device processing, lower utility use, automated workflow documentation, predictive maintenance, advanced drying, robotic instrument compatibility, room-level decontamination, and integrated air-quality management.

Conclusion

The U.S. Hospital Infection Control Equipment Market Size & Share is positioned to expand from approximately USD 3.72 billion in 2025 to USD 8.33 billion by 2035, representing a CAGR of 8.40% during 2026–2035. Historical market value increased from approximately USD 2.80 billion in 2021 to USD 3.46 billion in 2024 as hospitals rebuilt procedure volumes, strengthened infection-prevention infrastructure, and accelerated sterile processing modernization.

The market’s long-term growth is supported by structural rather than temporary factors: a hospital base exceeding 6,000 facilities, more than 907,000 staffed beds, almost 36 million annual admissions, persistent HAI risk, increasingly complex reusable medical devices, pressure on sterile-processing labor, quality-linked reimbursement, and growing procedural throughput.

Sterilization equipment will remain the largest product segment, while low-temperature processing, automated device reprocessing, endoscope drying and traceability, environmental decontamination, and selected airborne infection-control systems will generate stronger incremental growth.

From a procurement perspective, the competitive question is shifting from which equipment delivers the lowest acquisition price to which platform delivers the lowest operational risk and best lifecycle economics. Hospitals increasingly need evidence on throughput, device compatibility, instrument preservation, labor utilization, utility consumption, downtime, service coverage, traceability, and compliance.

Regionally, the South will remain the largest market because of population scale and health-system expansion, while the West is expected to show the strongest growth through technology adoption and new healthcare infrastructure. The Northeast will remain a premium, evidence-driven market led by academic medicine, while the Midwest will provide dependable replacement and modernization demand.

For manufacturers, investors, distributors, hospital procurement executives, and strategy teams evaluating the market through 2035, the strongest opportunities will concentrate around technologies that make infection prevention simultaneously safer, more automated, more measurable, and more economically efficient. Equipment manufacturers that combine validated clinical performance with superior workflow economics and enterprise-level service capability will be best positioned to gain share in the next generation of U.S. hospital infection-control infrastructure.

TABLE OF CONTENT

1. U.S. Hospital Infection Control Equipment Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Bottom-Up Validation & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Sterilization Equipment Manufacturers
1.6.2. Cleaning and Disinfection Equipment Manufacturers
1.6.3. Endoscope and Semi-Critical Device Reprocessing Companies
1.6.4. Environmental and No-Touch Decontamination Technology Providers
1.6.5. Hospital Systems and Integrated Delivery Networks
1.6.6. Sterile Processing Departments and Infection Prevention Teams
1.6.7. Group Purchasing Organizations and Medical Equipment Distributors
1.6.8. FDA, CMS, CDC, Accreditation Bodies and Clinical Decision-Makers

What this section provides: This section establishes the market definition, inclusion and exclusion criteria, research methodology, assumptions, hospital infection-control ecosystem, and key stakeholder groups used to measure and validate the U.S. Hospital Infection Control Equipment Market.

2. U.S. Hospital Infection Control Equipment Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Hospital Infection-Control Equipment Installed Base Assessment
2.8. High-Growth Opportunity Areas
2.9. Key Hospital Procurement Priorities
2.10. Strategic Opportunity Heatmap

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical performance, hospital demand patterns, installed equipment dynamics, growth pockets, procurement priorities, and high-value opportunities through 2035.

3. U.S. Hospital Infection Control Equipment Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Persistent Burden of Healthcare-Associated Infections
3.1.2. Modernization of Hospital Sterile Processing Departments
3.1.3. Rising Surgical and Endoscopy Procedure Volumes
3.1.4. Increasing Complexity of Reusable Medical Devices
3.1.5. Expansion of Robotic and Minimally Invasive Surgery
3.1.6. Growing Demand for Automated Endoscope Reprocessing
3.1.7. Hospital Focus on Sterile Processing Labor Productivity
3.1.8. CMS Quality Programs and Hospital-Acquired Condition Reduction Pressure
3.1.9. Increasing Focus on Airborne Infection Prevention and Hospital Preparedness
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Sterilization and Reprocessing Systems
3.2.2. Hospital Capital Budget Constraints
3.2.3. Sterile Processing Workforce Shortages
3.2.4. Reusable Device Compatibility and Validation Requirements
3.2.5. Equipment Maintenance, Downtime and Service Dependency
3.2.6. Long Replacement Cycles for Hospital Capital Equipment
3.3. Opportunities and Their Impact Analysis
3.3.1. Vaporized Hydrogen Peroxide and Low-Temperature Sterilization Expansion
3.3.2. Automated Endoscope Reprocessing and Controlled Drying
3.3.3. Digital Instrument Tracking and Reprocessing Traceability
3.3.4. UV-C and No-Touch Environmental Decontamination
3.3.5. Hospital Air Treatment and Supplemental Filtration Systems
3.3.6. Energy- and Water-Efficient Sterile Processing Equipment
3.3.7. Enterprise Sterile Processing Standardization Across IDNs
3.4. Challenges and Their Impact Analysis
3.4.1. Complex Manufacturer Instructions for Use
3.4.2. Cross-Departmental Infection-Control Workflow Variability
3.4.3. Instrument Turnaround and Capacity Bottlenecks
3.4.4. Evidence Requirements for Emerging Decontamination Technologies
3.4.5. Integration of New Equipment into Existing Hospital Infrastructure
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Healthcare-Associated Infection Risk and Equipment Demand Correlation
3.7. Clinical Workflow Economics Analysis
3.8. Sterile Processing Productivity and Capacity Analysis
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Equipment Replacement Cycle and Installed Base Analysis

What this section provides: This section evaluates the clinical, operational, regulatory, labor, capital expenditure, and technological forces shaping equipment demand and identifies the major commercial opportunities and execution risks facing suppliers.

4. U.S. Hospital Infection Control Equipment Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital Buyers
4.2.3. Bargaining Power of Component and Technology Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Capital Equipment Lifecycle Cost Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. Hospital Sterile Processing Workflow Analysis
4.7. Impact of Digitalization and Connected Sterile Processing
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework for Sterilization, Disinfection and Reprocessing Equipment
4.10. CMS Hospital Quality, HAI and Reimbursement Landscape
4.11. CDC Infection Prevention and Healthcare-Associated Infection Framework
4.12. Accreditation and Hospital Compliance Environment
4.13. Import/Export Restrictions & Tariff Impact
4.14. Government Initiatives and Public Health Programs
4.15. Sustainability, Water Consumption and Energy-Efficiency Analysis
4.16. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Total Cost of Ownership and ROI Assessment Framework

What this section provides: This section provides a comprehensive view of regulation, quality requirements, hospital economics, pricing, supply chains, sustainability, digitalization, technology adoption, and capital procurement criteria influencing the U.S. infection-control equipment industry.

5. U.S. Hospital Infection Control Equipment Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Sterilization Equipment
5.1.2.1. Steam Sterilizers
5.1.2.2. Low-Temperature Sterilizers
5.1.2.3. Vaporized Hydrogen Peroxide Sterilization Systems
5.1.2.4. Liquid Chemical Sterilization Systems
5.1.2.5. Dry Heat and Specialty Sterilization Systems
5.1.3. Cleaning and Disinfection Equipment
5.1.3.1. Washer-Disinfectors
5.1.3.2. Ultrasonic Cleaning Systems
5.1.3.3. Cart Washers
5.1.3.4. Automated Instrument Cleaning Systems
5.1.3.5. Flushing and Irrigation Systems
5.1.4. Endoscope and Semi-Critical Device Reprocessing Equipment
5.1.4.1. Automated Endoscope Reprocessors
5.1.4.2. Endoscope Drying and Storage Cabinets
5.1.4.3. Leak Testing Systems
5.1.4.4. Ultrasound Probe Disinfection Systems
5.1.4.5. Endoscope Transport and Workflow Equipment
5.1.5. Environmental and Room Decontamination Equipment
5.1.5.1. UV-C Room Disinfection Systems
5.1.5.2. Pulsed-Light Decontamination Systems
5.1.5.3. Hydrogen Peroxide Room Decontamination Systems
5.1.5.4. Automated No-Touch Disinfection Equipment
5.1.6. Air and Infection-Control Monitoring Equipment
5.1.6.1. HEPA Air Filtration Systems
5.1.6.2. UV Germicidal Irradiation Systems
5.1.6.3. Portable Air Decontamination Equipment
5.1.6.4. Sterilization Monitoring and Indicator Readers
5.1.6.5. Infection-Control Workflow Monitoring Hardware

What this section provides: This section identifies which hospital infection-control equipment categories generate the largest revenue contribution and evaluates the product areas expected to deliver the strongest growth through 2035.

6. U.S. Hospital Infection Control Equipment Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Surgical Instrument Reprocessing and Central Sterile Processing
6.1.3. Endoscopy and Flexible Device Reprocessing
6.1.4. Operating Rooms and Procedural Areas
6.1.5. Intensive Care Units and Isolation Areas
6.1.6. Emergency and High-Turnover Patient Care Areas
6.1.7. Oncology, Transplant and Immunocompromised Patient Care
6.1.8. Hospital-Wide Environmental and Support Services

What this section provides: This section evaluates equipment demand by hospital infection-control application and identifies the clinical workflows where sterilization, reprocessing, environmental decontamination, and engineering controls carry the greatest operational and economic importance.

7. U.S. Hospital Infection Control Equipment Market – By Hospital Type

7.1. Overview
7.1.1. Segment Share Analysis, By Hospital Type, 2025 & 2035 (%)
7.1.2. Large Acute-Care Hospitals and Integrated Health Systems
7.1.3. Academic and Teaching Hospitals
7.1.4. Community Hospitals
7.1.5. Critical Access and Rural Hospitals
7.1.6. Specialty Hospitals
7.1.6.1. Surgical Specialty Hospitals
7.1.6.2. Orthopedic Hospitals
7.1.6.3. Cancer Hospitals
7.1.6.4. Cardiovascular Hospitals
7.1.6.5. Children’s Hospitals
7.1.6.6. Other Specialty Hospitals

What this section provides: This section assesses how hospital size, procedural complexity, patient acuity, capital availability, sterile processing intensity, and procurement structures influence infection-control equipment purchasing across U.S. hospital types.

8. U.S. Hospital Infection Control Equipment Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Steam and Thermal Processing Technologies
8.1.3. Vaporized Hydrogen Peroxide and Low-Temperature Technologies
8.1.4. Automated Liquid Chemical Disinfection and Sterilization
8.1.5. Ultraviolet and No-Touch Environmental Decontamination
8.1.6. Filtration, Air Treatment and Engineering Controls
8.1.7. Digital Traceability and Connected Infection-Control Technologies

What this section provides: This section evaluates the technology platforms transforming hospital sterilization, device reprocessing, environmental decontamination, air management, and digital infection-control workflows.

9. U.S. Hospital Infection Control Equipment Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Medical Equipment Supplier Sales
9.1.6. Capital Leasing, Managed Equipment and Service-Based Agreements

What this section provides: This section explains how U.S. hospitals purchase infection-control equipment, including direct capital procurement, IDN standardization, GPO contracting, distribution channels, equipment leasing, lifecycle service agreements, and enterprise purchasing behavior.

10. U.S. Hospital Infection Control Equipment Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Infrastructure and Staffed Bed Analysis
10.1.4. Regional Surgical and Endoscopy Procedure Intensity Analysis
10.1.5. Regional HAI Prevention and Infection-Control Demand Analysis
10.1.6. Regional Capital Procurement and IDN Consolidation Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Hospital Buyers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Hospital Buyers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Hospital Buyers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Hospital Buyers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Hospital Type, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 U.S. states, enabling clients to identify hospital infrastructure hubs, sterile-processing investment hotspots, high-volume procedural markets, infection-control technology adoption patterns, and state-level commercial opportunities.

11. U.S. Hospital Infection Control Equipment Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking by Product Portfolio
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Analysis by Sterilization Installed Base
11.5. Competitive Analysis by Hospital Service and Maintenance Capability
11.6. Competitive Analysis by IDN and GPO Contracting Strength
11.7. Company Profiles

11.7.1. STERIS plc
11.7.2. Getinge AB
11.7.3. Advanced Sterilization Products
11.7.4. Ecolab Inc.
11.7.5. Olympus Corporation
11.7.6. SteelcoBelimed
11.7.7. Matachana Group
11.7.8. Tuttnauer
11.7.9. Stryker Corporation
11.7.10. Nanosonics Limited
11.7.11. CS Medical LLC
11.7.12. CIVCO Medical Solutions
11.7.13. Consolidated Sterilizer Systems
11.7.14. PRIMUS Sterilizer Company
11.7.15. Skytron LLC
11.7.16. Xenex Disinfection Services
11.7.17. PDI, Inc.
11.7.18. UVDI
11.7.19. Surfacide
11.7.20. TOMI Environmental Solutions
11.7.21. American Ultraviolet
11.7.22. 3M Company
11.7.23. Midmark Corporation
11.7.24. WellAir
11.7.25. MMM Group

Note: Each company profile will include company overview, U.S. infection-control equipment portfolio, sterilization and disinfection technology positioning, hospital customer strategy, installed-base strength, financial positioning, regulatory updates, product launches, partnerships, acquisitions, service capabilities, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, installed-base intelligence, hospital contracting capabilities, service differentiation, innovation direction, and strategic intelligence on major infection-control equipment manufacturers.

12. U.S. Hospital Infection Control Equipment Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Next-Generation Vaporized Hydrogen Peroxide Sterilization
12.2.2. Automated and Robotics-Compatible Instrument Reprocessing
12.2.3. Advanced Endoscope Reprocessing and Automated Drying
12.2.4. UV-C and Autonomous No-Touch Decontamination
12.2.5. Hospital Air Decontamination and Supplemental Filtration
12.2.6. AI-Assisted Sterile Processing Workflow Optimization
12.2.7. Instrument Tracking, Digital Traceability and Connected CSSD Platforms
12.3. Impact of Single-Use Medical Devices on Reprocessing Equipment Demand
12.4. Sustainability and Green Sterile Processing Outlook
12.5. Emerging Business Models
12.6. Business Opportunities for Startups and Existing Players
12.7. Investment Prioritization Matrix
12.8. Hospital Technology Adoption Curve, 2026–2035

What this section provides: This section prepares clients for changes in sterilization technology, automation, digital sterile processing, environmental decontamination, hospital air management, sustainability, procurement models, and investment opportunities through 2035.

13. U.S. Hospital Infection Control Equipment Market: Strategic Recommendations

13.1. Recommendations for Infection-Control Equipment Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Sterile Processing and Infection Prevention Leaders
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. U.S. Go-to-Market Strategy Considerations
13.8. IDN and GPO Contracting Strategy
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Hospital Capital Equipment Replacement Strategy
13.11. Service, Maintenance and Recurring Revenue Strategy
13.12. High-Growth State and Regional Prioritization Framework

What this section provides: This section converts market intelligence into actionable strategies for product positioning, hospital contracting, IDN penetration, regional expansion, investment prioritization, service revenue development, and long-term competitive differentiation.

14. U.S. Hospital Infection Control Equipment Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Estimation Limitation
14.4. Forecasting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s analytical boundaries, market-estimation assumptions, forecasting limitations, regulatory information limitations, data-use terms, and legal considerations.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Hospital Infection Control Equipment Market: Market Definition and Scope
TABLE 3: U.S. Hospital Infection Control Equipment Market: Research Methodology Framework
TABLE 4: U.S. Hospital Infection Control Equipment Market: Key Assumptions
TABLE 5: U.S. Hospital Infection Control Equipment Market: Market Ecosystem Overview
TABLE 6: U.S. Hospital Infection Control Equipment Market: Stakeholder Analysis
TABLE 7: U.S. Hospital Infection Control Equipment Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Hospital Infection Control Equipment Market: Analyst Viewpoint Summary
TABLE 9: U.S. Hospital Infection Control Equipment Market: Market Attractiveness Index
TABLE 10: U.S. Hospital Infection Control Equipment Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Hospital Infection Control Equipment Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Hospital Infection Control Equipment Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Hospital Infection Control Equipment Market: High-Growth Opportunity Areas
TABLE 14: U.S. Hospital Infection Control Equipment Market: Drivers; Impact Analysis
TABLE 15: U.S. Hospital Infection Control Equipment Market: Restraints; Impact Analysis
TABLE 16: U.S. Hospital Infection Control Equipment Market: Opportunities; Impact Analysis
TABLE 17: U.S. Hospital Infection Control Equipment Market: Challenges; Impact Analysis
TABLE 18: U.S. Hospital Infection Control Equipment Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Hospital Infection Control Equipment Market: Healthcare-Associated Infection Risk and Equipment Demand Matrix
TABLE 20: U.S. Hospital Infection Control Equipment Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Hospital Infection Control Equipment Market: Sterile Processing Productivity and Capacity Matrix
TABLE 22: U.S. Hospital Infection Control Equipment Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Hospital Infection Control Equipment Market: Equipment Replacement Cycle and Installed Base Analysis
TABLE 24: U.S. Hospital Infection Control Equipment Market: PESTEL Analysis
TABLE 25: U.S. Hospital Infection Control Equipment Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Hospital Infection Control Equipment Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Hospital Infection Control Equipment Market: Capital Equipment Lifecycle Cost Analysis
TABLE 28: U.S. Hospital Infection Control Equipment Market: Value Chain Analysis
TABLE 29: U.S. Hospital Infection Control Equipment Market: Supply Chain Analysis
TABLE 30: U.S. Hospital Infection Control Equipment Market: Hospital Sterile Processing Workflow Analysis
TABLE 31: U.S. Hospital Infection Control Equipment Market: Digitalization and Connected Sterile Processing Impact
TABLE 32: U.S. Hospital Infection Control Equipment Market: Application & Innovation Landscape
TABLE 33: U.S. Hospital Infection Control Equipment Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Hospital Infection Control Equipment Market: CMS HAI Quality and Reimbursement Landscape
TABLE 35: U.S. Hospital Infection Control Equipment Market: CDC Infection Prevention Framework
TABLE 36: U.S. Hospital Infection Control Equipment Market: Accreditation and Compliance Environment
TABLE 37: U.S. Hospital Infection Control Equipment Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Hospital Infection Control Equipment Market: Sustainability, Water and Energy-Efficiency Analysis
TABLE 39: U.S. Hospital Infection Control Equipment Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Hospital Infection Control Equipment Market: Product Category Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Product Category
TABLE 42: U.S. Hospital Infection Control Equipment Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 43: U.S. Hospital Infection Control Equipment Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 44: U.S. Hospital Infection Control Equipment Market: Sterilization Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Hospital Infection Control Equipment Market: Cleaning and Disinfection Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Hospital Infection Control Equipment Market: Endoscope and Semi-Critical Device Reprocessing Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Hospital Infection Control Equipment Market: Environmental and Room Decontamination Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Hospital Infection Control Equipment Market: Air and Infection-Control Monitoring Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Hospital Infection Control Equipment Market: Steam vs. Low-Temperature Sterilization Equipment Comparison
TABLE 50: U.S. Hospital Infection Control Equipment Market: Automated Endoscope Reprocessor Installed Base and Demand Outlook
TABLE 51: U.S. Hospital Infection Control Equipment Market: Application Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Application
TABLE 53: U.S. Hospital Infection Control Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 54: U.S. Hospital Infection Control Equipment Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 55: U.S. Hospital Infection Control Equipment Market: Surgical Instrument Reprocessing and Central Sterile Processing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Hospital Infection Control Equipment Market: Endoscopy and Flexible Device Reprocessing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Hospital Infection Control Equipment Market: Operating Rooms and Procedural Areas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Hospital Infection Control Equipment Market: Intensive Care Units and Isolation Areas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Hospital Infection Control Equipment Market: Emergency and High-Turnover Patient Care Areas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Hospital Infection Control Equipment Market: Oncology, Transplant and Immunocompromised Patient Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Hospital Infection Control Equipment Market: Hospital-Wide Environmental and Support Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Hospital Infection Control Equipment Market: Hospital Type Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Hospital Type
TABLE 64: U.S. Hospital Infection Control Equipment Market, by Hospital Type, 2021–2035 (US$ Billion)
TABLE 65: U.S. Hospital Infection Control Equipment Market: Segment Share Analysis, by Hospital Type, 2025 & 2035 (%)
TABLE 66: U.S. Hospital Infection Control Equipment Market: Large Acute-Care Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Hospital Infection Control Equipment Market: Academic and Teaching Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Hospital Infection Control Equipment Market: Community Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Hospital Infection Control Equipment Market: Critical Access and Rural Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Hospital Infection Control Equipment Market: Specialty Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Hospital Infection Control Equipment Market: Technology Type Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 73: U.S. Hospital Infection Control Equipment Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 74: U.S. Hospital Infection Control Equipment Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 75: U.S. Hospital Infection Control Equipment Market: Steam and Thermal Processing Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Hospital Infection Control Equipment Market: Vaporized Hydrogen Peroxide and Low-Temperature Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Hospital Infection Control Equipment Market: Automated Liquid Chemical Disinfection and Sterilization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Hospital Infection Control Equipment Market: Ultraviolet and No-Touch Environmental Decontamination Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Hospital Infection Control Equipment Market: Filtration, Air Treatment and Engineering Controls Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Hospital Infection Control Equipment Market: Digital Traceability and Connected Infection-Control Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Hospital Infection Control Equipment Market: Procurement Channel Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 83: U.S. Hospital Infection Control Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 84: U.S. Hospital Infection Control Equipment Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 85: U.S. Hospital Infection Control Equipment Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Hospital Infection Control Equipment Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Hospital Infection Control Equipment Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Hospital Infection Control Equipment Market: Distributor and Specialty Medical Equipment Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: U.S. Hospital Infection Control Equipment Market: Capital Leasing, Managed Equipment and Service-Based Agreements Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Hospital Infection Control Equipment Market: Regional Snapshot, 2025
TABLE 91: Segment Dashboard; Definition and Scope, by Region
TABLE 92: U.S. Hospital Infection Control Equipment Market, by Region, 2021–2035 (US$ Billion)
TABLE 93: U.S. Hospital Infection Control Equipment Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 94: U.S. Hospital Infection Control Equipment Market: Regional Hospital Infrastructure and Staffed Bed Analysis
TABLE 95: U.S. Hospital Infection Control Equipment Market: Regional Surgical and Endoscopy Procedure Intensity Analysis
TABLE 96: U.S. Hospital Infection Control Equipment Market: Regional HAI Prevention and Infection-Control Demand Analysis
TABLE 97: U.S. Hospital Infection Control Equipment Market: Regional Capital Procurement and IDN Consolidation Dynamics
TABLE 98: West Region U.S. Hospital Infection Control Equipment Market: Regional Overview and Trends
TABLE 99: West Region U.S. Hospital Infection Control Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 100: West Region U.S. Hospital Infection Control Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Hospital Infection Control Equipment Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Hospital Infection Control Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Hospital Infection Control Equipment Market, by Hospital Type, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Hospital Infection Control Equipment Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: West Region U.S. Hospital Infection Control Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 106: California Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 107: Washington Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 108: Arizona Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 109: Colorado Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 110: Oregon Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 111: Utah Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 112: Nevada Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 113: New Mexico Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 114: Idaho Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 115: Montana Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 116: Wyoming Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 117: Alaska Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 118: Hawaii Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Hospital Infection Control Equipment Market: Regional Overview and Trends
TABLE 120: Northeast Region U.S. Hospital Infection Control Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 121: Northeast Region U.S. Hospital Infection Control Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. Hospital Infection Control Equipment Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region U.S. Hospital Infection Control Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: Northeast Region U.S. Hospital Infection Control Equipment Market, by Hospital Type, 2021–2035 (US$ Billion)
TABLE 125: Northeast Region U.S. Hospital Infection Control Equipment Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 126: Northeast Region U.S. Hospital Infection Control Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: New York Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 128: Massachusetts Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 129: New Jersey Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 130: Pennsylvania Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 131: Connecticut Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 132: Maine Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 133: Vermont Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 134: New Hampshire Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 135: Rhode Island Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 136: Delaware Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Hospital Infection Control Equipment Market: Regional Overview and Trends
TABLE 138: South Region U.S. Hospital Infection Control Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 139: South Region U.S. Hospital Infection Control Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. Hospital Infection Control Equipment Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: South Region U.S. Hospital Infection Control Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: South Region U.S. Hospital Infection Control Equipment Market, by Hospital Type, 2021–2035 (US$ Billion)
TABLE 143: South Region U.S. Hospital Infection Control Equipment Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: South Region U.S. Hospital Infection Control Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Texas Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 146: Florida Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 147: Georgia Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 148: North Carolina Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 149: Tennessee Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 150: South Carolina Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 151: Alabama Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 152: Mississippi Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 153: Louisiana Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 154: Arkansas Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 155: Kentucky Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 156: Oklahoma Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 157: Virginia Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 158: Maryland Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 159: West Virginia Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Hospital Infection Control Equipment Market: Regional Overview and Trends
TABLE 161: Midwest Region U.S. Hospital Infection Control Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 162: Midwest Region U.S. Hospital Infection Control Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. Hospital Infection Control Equipment Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: Midwest Region U.S. Hospital Infection Control Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: Midwest Region U.S. Hospital Infection Control Equipment Market, by Hospital Type, 2021–2035 (US$ Billion)
TABLE 166: Midwest Region U.S. Hospital Infection Control Equipment Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: Midwest Region U.S. Hospital Infection Control Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Illinois Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 169: Ohio Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 170: Michigan Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 171: Minnesota Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 172: Indiana Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 173: Wisconsin Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 174: Missouri Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 175: Iowa Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 176: Kansas Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 177: Nebraska Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 178: North Dakota Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 179: South Dakota Hospital Infection Control Equipment Market Size, Forecast and Key Segment Analysis, 2021–2035 (US$ Billion)
TABLE 180: U.S. Hospital Infection Control Equipment Market: Competitive Landscape Snapshot, 2025
TABLE 181: U.S. Hospital Infection Control Equipment Market: Key Company Market Share Analysis, 2025
TABLE 182: U.S. Hospital Infection Control Equipment Market: Company Positioning Matrix
TABLE 183: U.S. Hospital Infection Control Equipment Market: Product Portfolio Benchmarking of Key Players
TABLE 184: U.S. Hospital Infection Control Equipment Market: Sterilization Installed Base Competitive Analysis
TABLE 185: U.S. Hospital Infection Control Equipment Market: Hospital Service and Maintenance Capability Benchmarking
TABLE 186: U.S. Hospital Infection Control Equipment Market: IDN and GPO Contracting Strength Benchmarking
TABLE 187: U.S. Hospital Infection Control Equipment Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 188: STERIS plc: Company Profile
TABLE 189: Getinge AB: Company Profile
TABLE 190: Advanced Sterilization Products: Company Profile
TABLE 191: Ecolab Inc.: Company Profile
TABLE 192: Olympus Corporation: Company Profile
TABLE 193: SteelcoBelimed: Company Profile
TABLE 194: Matachana Group: Company Profile
TABLE 195: Tuttnauer: Company Profile
TABLE 196: Stryker Corporation: Company Profile
TABLE 197: Nanosonics Limited: Company Profile
TABLE 198: CS Medical LLC: Company Profile
TABLE 199: CIVCO Medical Solutions: Company Profile
TABLE 200: Consolidated Sterilizer Systems: Company Profile
TABLE 201: PRIMUS Sterilizer Company: Company Profile
TABLE 202: Skytron LLC: Company Profile
TABLE 203: Xenex Disinfection Services: Company Profile
TABLE 204: PDI, Inc.: Company Profile
TABLE 205: UVDI: Company Profile
TABLE 206: Surfacide: Company Profile
TABLE 207: TOMI Environmental Solutions: Company Profile
TABLE 208: American Ultraviolet: Company Profile
TABLE 209: 3M Company: Company Profile
TABLE 210: Midmark Corporation: Company Profile
TABLE 211: WellAir: Company Profile
TABLE 212: MMM Group: Company Profile
TABLE 213: U.S. Hospital Infection Control Equipment Market: Future Market Scenario Analysis, 2026–2035
TABLE 214: U.S. Hospital Infection Control Equipment Market: Disruptive Technologies Impact Matrix
TABLE 215: U.S. Hospital Infection Control Equipment Market: Single-Use Device Impact on Reprocessing Equipment Demand
TABLE 216: U.S. Hospital Infection Control Equipment Market: Sustainability and Green Sterile Processing Outlook
TABLE 217: U.S. Hospital Infection Control Equipment Market: Emerging Business Models
TABLE 218: U.S. Hospital Infection Control Equipment Market: Business Opportunities for Startups and Existing Players
TABLE 219: U.S. Hospital Infection Control Equipment Market: Investment Prioritization Matrix
TABLE 220: U.S. Hospital Infection Control Equipment Market: Hospital Technology Adoption Curve, 2026–2035
TABLE 221: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for Equipment Manufacturers
TABLE 222: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 223: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for Sterile Processing and Infection Prevention Leaders
TABLE 224: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 225: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 226: U.S. Hospital Infection Control Equipment Market: Strategic Recommendations for New Entrants and Startups
TABLE 227: U.S. Hospital Infection Control Equipment Market: U.S. Go-to-Market Strategy Considerations
TABLE 228: U.S. Hospital Infection Control Equipment Market: IDN and GPO Contracting Strategy
TABLE 229: U.S. Hospital Infection Control Equipment Market: Product Positioning and Portfolio Expansion Guidance
TABLE 230: U.S. Hospital Infection Control Equipment Market: High-Growth State and Regional Prioritization Framework
TABLE 231: U.S. Hospital Infection Control Equipment Market: Scope Limitation
TABLE 232: U.S. Hospital Infection Control Equipment Market: Data Use Limitation
TABLE 233: U.S. Hospital Infection Control Equipment Market: Market Estimation Limitation
TABLE 234: U.S. Hospital Infection Control Equipment Market: Forecasting Limitation
TABLE 235: U.S. Hospital Infection Control Equipment Market: Legal Disclaimer
TABLE 236: U.S. Hospital Infection Control Equipment Market: Third-Party Data Disclaimer
TABLE 237: U.S. Hospital Infection Control Equipment Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Hospital Infection Control Equipment Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Healthcare-Associated Infection Risk and Equipment Demand Framework
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Sterile Processing Productivity and Capacity Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: U.S. Hospital Infection Control Equipment Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Hospital Infection Control Equipment Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Hospital Infection-Control Equipment Installed Base and Replacement Cycle
FIGURE 19: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 20: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Sterilization Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Cleaning and Disinfection Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Endoscope and Semi-Critical Device Reprocessing Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Environmental and Room Decontamination Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Air and Infection-Control Monitoring Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Steam vs. Low-Temperature Sterilization Technology Adoption
FIGURE 27: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Surgical Instrument Reprocessing and Central Sterile Processing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Endoscopy and Flexible Device Reprocessing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Operating Rooms and Procedural Areas Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Intensive Care Units and Isolation Areas Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Emergency and High-Turnover Patient Care Areas Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Oncology, Transplant and Immunocompromised Patient Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Hospital-Wide Environmental and Support Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Hospital Type Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Hospital Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Large Acute-Care Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Academic and Teaching Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Community Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Critical Access and Rural Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Specialty Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Steam and Thermal Processing Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Vaporized Hydrogen Peroxide and Low-Temperature Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Automated Liquid Chemical Disinfection and Sterilization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Ultraviolet and No-Touch Environmental Decontamination Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Filtration, Air Treatment and Engineering Controls Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Digital Traceability and Connected Infection-Control Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 52: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Distributor and Specialty Medical Equipment Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Capital Leasing, Managed Equipment and Service-Based Agreements Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 59: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Regional Hospital Infrastructure and Staffed Bed Comparison
FIGURE 61: Regional HAI Prevention and Infection-Control Equipment Demand Heatmap
FIGURE 62: West Region U.S. Hospital Infection Control Equipment Market Share and Leading Players, 2025
FIGURE 63: West Region Market Share Analysis by State, 2025
FIGURE 64: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: California Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Washington Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Arizona Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Colorado Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Oregon Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Utah Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Nevada Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: New Mexico Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Idaho Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Montana Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Wyoming Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Alaska Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Hawaii Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Northeast Region U.S. Hospital Infection Control Equipment Market Share and Leading Players, 2025
FIGURE 79: Northeast Region Market Share Analysis by State, 2025
FIGURE 80: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New York Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Massachusetts Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New Jersey Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Pennsylvania Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Connecticut Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Maine Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Vermont Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: New Hampshire Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Rhode Island Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Delaware Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: South Region U.S. Hospital Infection Control Equipment Market Share and Leading Players, 2025
FIGURE 92: South Region Market Share Analysis by State, 2025
FIGURE 93: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Texas Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Florida Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Georgia Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: North Carolina Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Tennessee Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: South Carolina Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Alabama Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Mississippi Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Louisiana Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Arkansas Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Kentucky Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Oklahoma Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Virginia Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Maryland Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: West Virginia Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Midwest Region U.S. Hospital Infection Control Equipment Market Share and Leading Players, 2025
FIGURE 110: Midwest Region Market Share Analysis by State, 2025
FIGURE 111: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Illinois Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Ohio Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Michigan Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Minnesota Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Indiana Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Wisconsin Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Missouri Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Iowa Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Kansas Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Nebraska Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: North Dakota Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: South Dakota Hospital Infection Control Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 125: Company Positioning Matrix
FIGURE 126: Key Player Product Portfolio Benchmarking
FIGURE 127: Sterilization Installed Base Competitive Benchmarking
FIGURE 128: Hospital Service and Maintenance Capability Benchmarking
FIGURE 129: IDN and GPO Contracting Strength Benchmarking
FIGURE 130: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 131: Hospital Infection Control Equipment Innovation Roadmap
FIGURE 132: Future Market Scenario Analysis, 2026–2035
FIGURE 133: Disruptive Technologies Impact Matrix
FIGURE 134: Next-Generation Low-Temperature Sterilization Adoption Roadmap
FIGURE 135: Advanced Endoscope Reprocessing and Drying Opportunity Map
FIGURE 136: UV-C and No-Touch Decontamination Adoption Roadmap
FIGURE 137: Hospital Air Decontamination and Filtration Opportunity Map
FIGURE 138: Digital Traceability and Connected Sterile Processing Roadmap
FIGURE 139: Sustainability and Green Sterile Processing Outlook
FIGURE 140: Investment Prioritization Matrix
FIGURE 141: Strategic Growth Roadmap for U.S. Hospital Infection Control Equipment Companies
FIGURE 142: Go-to-Market Strategy Framework
FIGURE 143: IDN and GPO Contracting Strategy Framework
FIGURE 144: Product Positioning and Portfolio Expansion Framework
FIGURE 145: High-Growth State and Regional Prioritization Map
FIGURE 146: Report Scope and Disclaimer Framework